Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Yi-long Wu

Fusion of EML4 and ALK Is Associated With Development of Lung Adenocarcinomas Lacking EGFR and KRAS Mutations and Is Correlated With ALK Expression

Molecular Cancer

English

Neoadjuvant Crizotinib in Resectable Locally Advanced Non-Small-Cell Lung Cancer With ALK-rearrangement: A Brief Report

Journal of Thoracic Oncology

English

Related publications

ALK Fusion Protein Expression in Lung Adenocarcinoma and Its Correlation With EGFR Protein Expression

Madridge Journal of Oncogenesis

2018

English

Carcinoma of Unknown Primary With EML4‐ALK Fusion Response to ALK Inhibitors

English

EMT Is Associated With, but Does Not Drive Resistance to ALK Inhibitors Among EML4-ALK Non-Small Cell Lung Cancer

English

Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK Among Treatment-Naïve Patients With Advanced Lung Adenocarcinoma

PLoS ONE

Multidisciplinary

2016

English

Preoperative Serum Carcinoembryonic Antigen Levels Are Associated With Histologic Subtype, EGFR Mutations, and ALK Fusion in Patients With Completely Resected Lung Adenocarcinoma

OncoTargets and Therapy

Oncology

Pharmacology

2017

English

PCR-based Detection of EGFR, ALK, KRAS and BRAF Mutations in Russian Patients With Lung Adenocarcinoma: A Single-Center Experience

Neoplasma

Cancer Research

2018

English

Association Between EML4-ALK Fusion Gene and Thymidylate Synthase mRNA Expression in Non-Small Cell Lung Cancer Tissues

Experimental and Therapeutic Medicine

English

P07 Preliminary Orthogonal Analysis of EML4-ALK Gene Fusion Detection Methods in Chilean Patients With Lung Adenocarcinoma

Journal of Thoracic Oncology

English

Detection of ALK Rearrangement by Immunohistochemistry in Lung Adenocarcinoma and the Identification of a Novel EML4-ALK Variant

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Yi-long Wu

Fusion of EML4 and ALK Is Associated With Development of Lung Adenocarcinomas Lacking EGFR and KRAS Mutations and Is Correlated With ALK Expression

Neoadjuvant Crizotinib in Resectable Locally Advanced Non-Small-Cell Lung Cancer With ALK-rearrangement: A Brief Report

Related publications

ALK Fusion Protein Expression in Lung Adenocarcinoma and Its Correlation With EGFR Protein Expression

Carcinoma of Unknown Primary With EML4‐ALK Fusion Response to ALK Inhibitors

EMT Is Associated With, but Does Not Drive Resistance to ALK Inhibitors Among EML4-ALK Non-Small Cell Lung Cancer

Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK Among Treatment-Naïve Patients With Advanced Lung Adenocarcinoma

Preoperative Serum Carcinoembryonic Antigen Levels Are Associated With Histologic Subtype, EGFR Mutations, and ALK Fusion in Patients With Completely Resected Lung Adenocarcinoma

PCR-based Detection of EGFR, ALK, KRAS and BRAF Mutations in Russian Patients With Lung Adenocarcinoma: A Single-Center Experience

Association Between EML4-ALK Fusion Gene and Thymidylate Synthase mRNA Expression in Non-Small Cell Lung Cancer Tissues

P07 Preliminary Orthogonal Analysis of EML4-ALK Gene Fusion Detection Methods in Chilean Patients With Lung Adenocarcinoma

Detection of ALK Rearrangement by Immunohistochemistry in Lung Adenocarcinoma and the Identification of a Novel EML4-ALK Variant